CVS Health Corporation $CVS Stock Position Boosted by Callodine Capital Management LP

Callodine Capital Management LP grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 78.6% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 518,000 shares of the pharmacy operator’s stock after acquiring an additional 228,000 shares during the period. CVS Health comprises approximately 3.7% of Callodine Capital Management LP’s investment portfolio, making the stock its 10th biggest holding. Callodine Capital Management LP’s holdings in CVS Health were worth $35,732,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Avion Wealth lifted its holdings in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 189 shares during the period. Harbor Asset Planning Inc. purchased a new stake in CVS Health in the second quarter worth about $30,000. Bell Investment Advisors Inc grew its holdings in CVS Health by 119.8% during the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock worth $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC raised its holdings in shares of CVS Health by 78.3% in the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares in the last quarter. Finally, ORG Partners LLC lifted its position in shares of CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have weighed in on CVS shares. Royal Bank Of Canada restated an “outperform” rating on shares of CVS Health in a report on Thursday. Morgan Stanley upped their price objective on CVS Health from $82.00 to $89.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 14th. Wall Street Zen downgraded shares of CVS Health from a “buy” rating to a “hold” rating in a research report on Saturday, November 1st. Baird R W upgraded shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Mizuho lifted their price target on shares of CVS Health from $76.00 to $88.00 and gave the stock an “outperform” rating in a report on Thursday, October 9th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $90.95.

CVS Health Stock Down 1.6%

NYSE:CVS opened at $75.52 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. CVS Health Corporation has a twelve month low of $43.56 and a twelve month high of $85.15. The company has a market cap of $95.87 billion, a PE ratio of 198.74, a P/E/G ratio of 0.74 and a beta of 0.48. The company’s 50 day moving average is $78.75 and its two-hundred day moving average is $71.29.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter last year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 3.5%. The ex-dividend date was Thursday, October 23rd. CVS Health’s payout ratio is presently 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.